Sensitisation of Candida albicans to killing by low-power laser light.

The purpose of this study was to determine whether Candida albicans, and other Candida spp. responsible for HIV-associated candidosis, could be sensitised to killing by low-power laser light. Suspensions of C. albicans were treated with a number of potential photosensitisers, exposed to laser light from a Helium/Neon (HeNe) or Gallium aluminium arsenide (GaAs) laser for 120 s and survivors enumerated. Toluidine blue O (TBO), thionin and crystal violet were able to sensitise the yeast to killing by light from the HeNe laser (energy dose = 876 mJ at a density of 66.36 J/cm2), the kills achieved being 6.8 x 10(6) cfu/ml, 3.1 x 10(6) cfu/ml and 1.3 x 10(6) cfu/ml respectively. TBO was also able to sensitise several other Candida spp. to killing by HeNe laser light. Dihaematoporphyrin ester was not an effective photosensitiser under the conditions employed. Methylene blue, but not aluminium disulphonated phthalocyanine, was able to sensitise C. albicans to killing by light from the GaAs laser (energy dose 1.32 J at a density of 2.04 J/cm2). The viability of the yeast was not affected by exposure to laser light in the absence of the photosensitisers. As killing of dye-sensitised C. albicans, and other Candida spp., could be achieved by exposure to low-power laser light for short periods of time, this approach merits further investigation as a potential therapeutic modality for HIV-associated candidosis.

[1]  M. Wilson,et al.  Sensitization of periodontopathogenic bacteria to killing by light from a low-power laser. , 1993, Oral microbiology and immunology.

[2]  T. Dubbelman,et al.  Photodynamic treatment of yeast cells with the dye toluidine blue: all-or-none loss of plasma membrane barrier properties. , 1992, Biochimica et biophysica acta.

[3]  E. Helm,et al.  Change of Causative Organisms under Antifungal Treatment in Immunosuppressed Patients with HIV‐Infections , 1989, Mycoses.

[4]  G. Bertoloni,et al.  Factors influencing the haematoporphyrin-sensitized photoinactivation of Candida albicans. , 1989, Journal of general microbiology.

[5]  M. Ollert,et al.  In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus , 1988, Journal of clinical microbiology.

[6]  A. Glatt,et al.  Treatment of Infections Associated with Human Immunodeficiency Virus , 1988 .

[7]  E. Johnson,et al.  In-vitro resistance to imidazole antifungals in Candida albicans. , 1984, The Journal of antimicrobial chemotherapy.

[8]  T. Ito,et al.  PHOTODYNAMIC ACTION OF HEMATOPORPHYRIN ON YEAST CELLS—A KINETIC APPROACH , 1981, Photochemistry and photobiology.

[9]  J. Moan,et al.  PHOTODYNAMIC INACTIVATION OF YEAST CELLS SENSITIZED BY HEMATOPORPHYRIN , 1980, Photochemistry and photobiology.

[10]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[11]  T. Ito,et al.  TOLUIDINE BLUE: THE MODE OF PHOTODYNAMIC ACTION IN YEAST CELLS , 1977, Photochemistry and photobiology.

[12]  J. D. Macmillan,et al.  LETHAL PHOTOSENSITIZATION OF MICROORGANISMS WITH LIGHT FROM A CONTINUOUS‐WAVE GAS LASER , 1966, Photochemistry and photobiology.

[13]  Z. Malik,et al.  New trends in photobiology (Invited review) bactericidal effects of photoactivated porphyrins ― An alternative approach to antimicrobial drugs , 1990 .

[14]  F. R. Venezio,et al.  Bactericidal effects of photoradiation therapy with hematoporphyrin derivative. , 1985, The Journal of infectious diseases.